The observations suggest that the tumor suppressor gene CDKN2 is a potential candidate for ge ne replacement therapy of NSCLC.
结果表明肿瘤抑制基因CDKN2可望成为NSCLC基因替代治疗的候选基因。
Its potential homologue MIM-B is also thought to code a putative tumor metastasis suppressor protein.
MIM可能的同系物mim - B同样被认为编码一种假定的转移抑制蛋白。
With the new technique, it is possible to identify potential tumour-suppressor genes from among the approximately 25,000 human genes and accelerate research significantly.
运用这种新技术,可以在大约25,000个人类基因中鉴别出肿瘤抑制基因,并且显著加快研究进程。
应用推荐